Walder Wyss AG has advised CeQur SA. CeQur SA, a Swiss medical device company specializing in insulin-delivery solutions for people with diabetes, has completed a USD...
CeQur SA Completes USD 100 Million Series E Financing Round
CeQur SA’s $115 Million Series C5 Financing Round
Walder Wyss AG advised CeQur SA in the financing. CeQur SA a Swiss medical device company committed to simplifying the lives of people with diabetes by...


























